September 7, 2014 | Foam-based drugs developer Foamix announced that it expects to raise $71 million in its upcoming NASDAQ IPO, according to the company prospectus. Additionally, the company noted that it could raise up to $81 million if the underwriters exercise of their options, at a company value of $239 million, after money. The company plans to offer up 6 million shares at a price of between $10-$12 a piece. The underwriters for the offering, scheduled to take place on September 18, are Barclays Investment Bank, Cowen, Oppenheimer, and Maxim group.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

$10M For Cyber Company That Protects Small Businesses
January 31, 2023

Phone-Block Technology For School Bus Drivers
January 31, 2023

Israeli Patients Can Now WhatsApp Their Doctor
January 31, 2023

People With Autism Experience Higher Intensity Pain
January 30, 2023
Facebook comments